Gynecologic Cancer

Top Story

Nucleos(t)ide therapy for HBV does not increase risk for all cancers

May 3, 2016

BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive long-term treatment with nucleos(t)ide analogues did not have an increased risk for all cancers. However, a slight increase in the development of colorectal and cervical cancers was observed, suggesting routine screening for these types of cancers among these patients is necessary.

Grace Wong, MD, professor in the department of medicine and therapeutics at The Chinese University of Hong Kong, and colleagues evaluated the data of 44,494 patients with chronic HBV found in the Hospital Authority database between 2000 and 2012. Of these patients, 4,782 were treated with nucleos(t)ide analogues and 39,712 were not. The primary outcome was the incidence of malignancies other than hepatocellular carcinoma.

Indiana University Health Simon Cancer Center yoga program eases stress associated with diagnosis, treatment

May 2, 2016
Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.A patient’s quality of life may…
Meeting News Coverage

Adolescents with anxiety, depression more likely to exhibit HPV persistence

May 1, 2016
BALTIMORE — Stress and maladaptive coping mechanisms impacted HPV acquisition and persistence among girls and women, indicating a link between psychosocial…
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

VIDEO: HPV vaccination trial provides 'reassuring' data on multisite protection

April 28, 2015
More »
Featured
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Meeting News Coverage

Nucleos(t)ide therapy for HBV does not increase risk for all cancers

May 3, 2016
BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive…

Indiana University Health Simon Cancer Center yoga program eases stress associated with diagnosis, treatment

May 2, 2016
Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.A patient’s…

Meeting News Coverage

Adolescents with anxiety, depression more likely to exhibit HPV persistence

May 1, 2016
BALTIMORE — Stress and maladaptive coping mechanisms impacted HPV acquisition and persistence among girls and women, indicating a link between…

In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…

In the JournalsPerspective

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment…

Meeting News Coverage

Switch from quadrivalent to 9-valent vaccine could reduce HPV prevalence

April 28, 2016
BALTIMORE — Adoption of the 9-valent vaccine over the quadrivalent vaccine as the primary method of HPV immunization in the United States could…

Meeting News Coverage

BGB-283 effective against tumors with BRAF, RAS mutations

April 24, 2016
NEW ORLEANS — An investigational agent designed to target the RAF family of proteins demonstrated clinical activity in patients with cancer who…

FDA News

FDA grants orphan drug designation to VAL-083 for ovarian cancer

April 22, 2016
The FDA granted orphan drug designation to dianhydrogalactitol for the treatment of patients with

Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice…

Meeting News CoverageVideo

VIDEO: Liquid biopsies valuable but will not eliminate need to assess tumor tissue

April 17, 2016
NEW ORLEANS — Filip Janku, MD, PhD, medical oncologist at The University of Texas MD Anderson Cancer Center, spoke to HemOnc Today about the…

More Headlines »
morganatic-roan morganatic-roan